These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35625823)

  • 1. Cathelicidin LL-37 in Health and Diseases of the Oral Cavity.
    Tokajuk J; Deptuła P; Piktel E; Daniluk T; Chmielewska S; Wollny T; Wolak P; Fiedoruk K; Bucki R
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus.
    Moreno-Angarita A; Aragón CC; Tobón GJ
    J Transl Autoimmun; 2020; 3():100029. PubMed ID: 32743514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview of Physical, Microbiological and Immune Barriers of Oral Mucosa.
    Şenel S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?].
    Schauber J; Ruzicka T; Rupec RA
    Hautarzt; 2008 Jan; 59(1):72-4. PubMed ID: 18209993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease.
    Reinholz M; Ruzicka T; Schauber J
    Ann Dermatol; 2012 May; 24(2):126-35. PubMed ID: 22577261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in
    Rather IA; Sabir JSM; Asseri AH; Ali S
    J Fungi (Basel); 2022 Feb; 8(2):. PubMed ID: 35205958
    [No Abstract]   [Full Text] [Related]  

  • 7. The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs.
    Kuroda K; Okumura K; Isogai H; Isogai E
    Front Oncol; 2015; 5():144. PubMed ID: 26175965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of cathelicidins in inflammation and bone loss.
    Nakamichi Y; Horibe K; Takahashi N; Udagawa N
    Odontology; 2014 Jul; 102(2):137-46. PubMed ID: 25047111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial antimicrobial peptides: guardian of the oral cavity.
    Hans M; Madaan Hans V
    Int J Pept; 2014; 2014():370297. PubMed ID: 25435884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases.
    Chen K; Gong W; Huang J; Yoshimura T; Wang JM
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1362-1372. PubMed ID: 34856773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Host Defence Peptides: Immunomodulatory Functions and Translational Prospects.
    van der Does AM; Hiemstra PS; Mookherjee N
    Adv Exp Med Biol; 2019; 1117():149-171. PubMed ID: 30980358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial peptide control of pathogenic microorganisms of the oral cavity: a review of the literature.
    da Silva BR; de Freitas VA; Nascimento-Neto LG; Carneiro VA; Arruda FV; de Aguiar AS; Cavada BS; Teixeira EH
    Peptides; 2012 Aug; 36(2):315-21. PubMed ID: 22664320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory streptococci that inhibit CXCL8 secretion and NFκB activation are common members of the oral microbiota.
    Myers S; Do T; Meade JL; Tugnait A; Vernon JJ; Pistolic J; Hancock REW; Marsh PD; Trivedi HM; Chen D; Devine DA
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33734952
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of cutaneous antimicrobial peptides by vitamin D3.
    Dombrowski Y; Peric M; Koglin S; Ruzicka T; Schauber J
    Arch Dermatol Res; 2010 Aug; 302(6):401-8. PubMed ID: 20221619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal diseases: Oral dysbiosis in susceptible hosts.
    Villar CC; Dongari-Bagtzoglou A
    Periodontol 2000; 2021 Oct; 87(1):166-180. PubMed ID: 34463992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of innate host defense proteins in oral cancerogenesis.
    Winter J; Jepsen S
    Periodontol 2000; 2024 Jan; ():. PubMed ID: 38265172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections.
    Majewski K; Kozłowska E; Żelechowska P; Brzezińska-Błaszczyk E
    Cent Eur J Immunol; 2018; 43(4):453-457. PubMed ID: 30799994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.
    Tzitzilis A; Boura-Theodorou A; Michail V; Papadopoulos S; Krikorian D; Lekka ME; Koukkou AI; Sakarellos-Daitsiotis M; Panou-Pomonis E
    J Pept Sci; 2020 Jul; 26(7):e3254. PubMed ID: 32567085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37.
    Zhang Y; Lakshmaiah Narayana J; Wu Q; Dang X; Wang G
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling brain aging through the lens of oral microbiota.
    Hu Q; Wang S; Zhang W; Qu J; Liu GH
    Neural Regen Res; 2024 Jul; ():. PubMed ID: 38993126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.